Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms.
Journal: The Journal of antimicrobial chemotherapy
Published: July 20, 2023
Treatment of common respiratory tract infections.
Journal: The Medical letter on drugs and therapeutics
Published: April 11, 2023
A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria.
Journal: Future microbiology
Published: March 14, 2022
Development, validation, and application of an LC-MS/MS method for the quantification of the novel antibiotic drug lefamulin (Xenleta®) and its main metabolite 2R-hydroxy lefamulin in human plasma.
Journal: Journal of pharmaceutical and biomedical analysis
Published: April 02, 2021
Antibacterial drugs for community-acquired pneumonia.
Journal: The Medical letter on drugs and therapeutics
Published: January 29, 2021
Lefamulin (Xenleta) for the Treatment of Community-Acquired Bacterial Pneumonia.
Journal: American family physician
Published: September 15, 2020
Clinical Utility of Lefamulin: If Not Now, When?
Journal: Current infectious disease reports
Published: August 25, 2020
Lefamulin (Xenleta) for Community-Acquired Bacterial Pneumonia.
Journal: JAMA
Published: November 06, 2019
Lefamulin (Xenleta) for community-acquired bacterial pneumonia.
Journal: The Medical letter on drugs and therapeutics
Published: October 11, 2019
Showing 1-9 of 9
Last Updated: 10/31/2025